23rd State of the Art Management of Infectious Diseases

Saturday, March 23, 2024, 8:00 AM - 3:00 PM, Digital Futures Building 3080 Exploration Ave., Cincinnati, OH

AMA PRA Category 1 Credits™ (5.25 hours), AMA PRA Category 1 Credits™ Designated (5.25 hours)


The 23rd Annual State of the Art Conference will feature presentations that will focus on HIV cure, REPRIEVE, CROI Updates, Primary Care for PWH, and cased based learning. This conference will feature expert speakers around the nation.  

REGISTER HERE!

In-person registration: https://matec.caspio.com/dp/BA50700090280c9da9194a3daf9c?ER_ID=40615

For individuals located outside of Cincinnati, OH, there is a virtual option available.
Virtual registration: https://matec.caspio.com/dp/BA50700090280c9da9194a3daf9c?ER_ID=40616

1. Explain barriers like the HIV reservoir represent a challenge to developing an HIV cure
2. Describe benefits of using pitavastatin to lower cardiovascular risk in People with HIV (PWH)
3. Identify relevant HIV clinical research updates from the 2024 Conference on Retroviruses and Opportunistic Infections
4. Define appropriate evaluation and management of newly diagnosed persons with HIV
5. Describe reasons why persons may fail long-acting therapy with cabotegravir-rilpivirine.

The University of Cincinnati is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.  The University of Cincinnati designates this live activity for a maximum of 5.25 AMA PRA Category 1 Credits™.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.


The opinions expressed during the live activity are those of the faculty and do not necessarily represent the views of the University of Cincinnati. The information is presented for the purpose of advancing the attendees' professional development.

Mitigation of Relevant Financial Relationships

The University of Cincinnati adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control content of a CME activity, including faculty, planners, reviewers, or others, are required to disclose all financial relationships with ineligible entities (commercial interests) over the last 24-months. All relevant relationships have been mitigated prior to the commencement of the activity.

Information regarding the new updated ACCME Standards for Integrity and Independence in Accredited Continuing Education can be found on the ACCME website.

No faculty are available for this activity at this time.

We gratefully acknowledge the following companies for their educational grants in support of this educational activity:
Gilead Sciences, Inc.
ViiV Healthcare

We gratefully acknowledge the following companies for having exhibits at our conference:
Gilead Sciences, Inc.
InsMed
Janssen Pharmaceutical Companies
Merck
Thera Technologies
ViiV Healthcare

This conference is supported by the Health Resources and Services Administration (HRSA) of the U.S. Department of Health and Human Services (HHS) as part of an award totaling $4,036,482.00 with 50 percentage financed with nongovernmental sources. The contents are those of the author(s) and do not necessarily represent the official views of, nor an endorsement, by HRSA, HHS or the U.S. Government.